Last reviewed · How we verify

NCT04038905

The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing

Status unknown Last updated 30 January 2020
What this trial tests

trial in BRCA Mutations in 300 participants. Status unknown.

Timeline
1 April 2020
Primary endpoint
30 April 2021
30 April 2022

Quick facts

Lead sponsorIgentify Ltd
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date1 April 2020
Primary completion30 April 2021
Estimated completion30 April 2022

Conditions studied

Sponsor

Igentify Ltd

Who can join

18 and older, female only, with BRCA Mutations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The DGC provides an end-to-end solution to the Oncogenetics screening process from participant registration to receipt of the genetic test results and their interpretation. These steps are provided using personalized animated videos.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for BRCA Mutations

Currently open trials in the same condition.

Other Igentify Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing